KRN#

Related by string. * * candidate KRN# *

Related by context. All words. (Click for frequent words.) 74 Aflibercept 74 Romidepsin 73 MAGE A3 ASCI 73 Mipomersen 73 oral prodrug 72 Pazopanib 72 bicifadine 72 Pimavanserin 72 Golimumab 72 mapatumumab 72 Meets Primary Endpoint 72 ganetespib 72 evaluating tivozanib 71 diabetic neuropathic pain 71 Cloretazine 71 phase IIa clinical 71 Archexin 71 Panzem R NCD 71 Aliskiren 71 Cloretazine ® 71 pertuzumab 71 FOLOTYN ® 71 Daclizumab 71 sorafenib tablets 71 Omacetaxine 71 Phase IIb Trial 71 Phase 2b Clinical Trial 71 Elesclomol 71 oral rivaroxaban 70 Hsp# Inhibitor 70 sorafenib Nexavar 70 GW# [003] 70 alvespimycin 70 orally inhaled migraine 70 Phase III Clinical Trial 70 phase IIb clinical 70 adalimumab Humira 70 Dapagliflozin 70 liposomal formulation 70 TLK# 70 intranasal formulation 70 PNP inhibitor 70 Pertuzumab 70 Traficet EN 70 INCB# [001] 70 phase III isavuconazole 70 CIPN 70 Milnacipran 70 DDP# 70 LEVADEX ™ 70 AEGR 70 JAK inhibitor 70 AAG geldanamycin analog 70 Elagolix 70 cannabinor 70 elotuzumab 70 reslizumab 70 YONDELIS 70 dasatinib Sprycel ® 70 neratinib 70 galiximab 70 NP2 Enkephalin 70 pharmacokinetic PK study 70 lumiliximab 69 LibiGel ® 69 II Clinical Trial 69 Onrigin 69 Carfilzomib 69 midstage clinical 69 phase IIa 69 Bortezomib 69 PrevOnco 69 Ophena TM 69 ACTEMRA TM 69 Tyrima 69 Pivotal Phase III 69 IL# PE#QQR 69 Ambrisentan 69 Teriflunomide 69 Zemplar Capsules 69 MyVax R 69 dextromethorphan quinidine 69 pregabalin Lyrica 69 OMP #M# 69 huC# DM4 69 Corlux 69 Sapacitabine 69 Adalimumab 69 Bezielle 69 Tesetaxel 69 CIMZIA TM certolizumab pegol 69 tezampanel 69 Talabostat 69 pseudobulbar affect PBA 69 Hedgehog Pathway Inhibitor 69 Tanespimycin 69 rasagiline tablets 69 Darusentan 69 ZACTIMA 69 Phase IIb Clinical Trial 69 radiation sensitizer 69 dacetuzumab 69 class mGluR5 inhibitor 69 Phase IIA 69 metaglidasen 69 Initiates Phase III 69 Zenvia ™ 69 Vicriviroc 69 Phase IIa clinical 69 LymphoStat B TM 69 PKC# 69 phase IIb trial 69 Silodosin 69 novel oral anticoagulant 69 mertansine 69 Phase 1a clinical 69 ixabepilone 69 ZOLINZA 69 DermaVir Patch 69 PRT# 69 R lenalidomide 69 Tolvaptan 69 Phase 2a Trial 69 Anidulafungin 69 bevacizumab Avastin ® 69 Temsirolimus 69 oxymorphone ER 69 fosbretabulin 68 enzastaurin 68 Degarelix 68 baminercept 68 ThermoDox R 68 forodesine 68 Pemetrexed 68 tanespimycin 68 PDX pralatrexate 68 AQ4N 68 Completes Patient Enrollment 68 EOquin TM 68 systemic RNAi therapeutic 68 acyclovir Lauriad R 68 R#/MEM # 68 Investigational Treatment 68 Ocrelizumab 68 Intervention Effectiveness 68 Phase Ib clinical 68 Lubiprostone 68 Pyridorin 68 pan HDAC inhibitor 68 Virulizin ® 68 vidofludimus 68 Randomized Phase 68 LEVADEX TM 68 FASLODEX 68 Dalbavancin 68 Phase IIIb clinical 68 ospemifene 68 Fondaparinux 68 Epratuzumab 68 riociguat 68 selective androgen receptor modulator 68 Zenvia Phase III 68 GSK# [002] 68 Phase Ib study 68 histone deacetylase HDAC inhibitor 68 Initiate Clinical Trial 68 targeted radiotherapeutic 68 PD LID 68 PHX# 68 Phase 2a clinical 68 CYT# potent vascular disrupting 68 Nexavar ® 68 Cannabinor 68 dexanabinol 68 RhuDex ® 68 Bucindolol 68 investigational humanized monoclonal antibody 68 Serdaxin 68 OXi# 68 Chemophase 68 Iloperidone 68 teriflunomide 68 erlotinib Tarceva ® 68 virus HCV protease inhibitor 68 HGS ETR2 68 oral renin inhibitor 68 non nucleoside inhibitor 68 Amrubicin 68 Tipranavir 68 Phase III Trial 68 TASKi3 68 Ixempra 68 eosinophilic asthma 68 Muraglitazar 68 Hyphanox 68 Triapine 68 Vilazodone 68 Phase #b/#a clinical 68 romidepsin 68 Initiate Phase 68 Fulvestrant 68 novel histone deacetylase 68 Bicifadine 68 Gemzar ® 68 Luteinizing Hormone Releasing Hormone 68 cediranib 68 Phase 2b Trial 68 trastuzumab DM1 68 alvimopan 68 docetaxel Taxotere ® 68 Metastatic Melanoma 68 GLYX 67 PDE4 inhibitor 67 Annamycin 67 MGd 67 Zoraxel 67 PSN# [002] 67 PRX # 67 Azedra 67 thalidomide Thalomid 67 Irinotecan 67 RhuDex 67 sunitinib malate 67 rufinamide 67 Initiates Enrollment 67 vorinostat 67 Safinamide 67 CINQUIL 67 generation purine nucleoside 67 Eculizumab 67 alfa 2a 67 Pirfenidone 67 peripherally acting 67 JAK2 Inhibitor 67 Personalized Immunotherapy 67 TBC# 67 Neurodex 67 CR# vcMMAE 67 oral ridaforolimus 67 Perifosine 67 Sipuleucel T 67 adenosine injection 67 noninfectious uveitis 67 relapsed multiple myeloma 67 oral salmon calcitonin 67 preclinical efficacy 67 IAP inhibitors 67 IV Busulfex 67 IMiDs ® 67 Factor VIIa 67 Laquinimod 67 Androxal TM 67 Ixabepilone 67 nab paclitaxel 67 Xeloda ® 67 6R BH4 67 Dyloject TM 67 OncoVEX GM CSF 67 relapsing multiple sclerosis 67 aflibercept VEGF Trap 67 R roscovitine 67 Lacosamide 67 Aryplase 67 CLARITY study 67 ELACYT 67 Dasatinib 67 bevacizumab Avastin 67 gefitinib Iressa 67 interferon gamma 1b 67 Methylnaltrexone 67 receptor tyrosine kinase inhibitor 67 Mycophenolate Mofetil 67 Fibrillex TM 67 Azixa 67 aripiprazole Abilify 67 Xcytrin R 67 Civacir 67 RGB # 67 Clinical Trial Results 67 Phase 1b trial 67 Multiple Ascending Dose 67 TELINTRA 67 selective modulator 67 ORENCIA ® 67 Successfully Completes Phase 67 Presents Preclinical Data 67 EVIZON TM 67 lintuzumab 67 Phase III Trials 67 BAY #-# 67 OMP #R# 67 incyclinide 67 Zybrestat 67 JAK2 inhibitor 67 Phase 2b Study 67 docetaxel Taxotere R 67 Ozarelix 67 Panzem R 67 bosutinib 67 targeting CD# 67 dasatinib Sprycel 67 PEGylated Fab fragment 67 Fx #A 67 Ereska 67 canakinumab 67 unique alkylating agent 67 Melphalan 67 Patients Treated With 67 vinorelbine tartrate 67 recurrent GBM 67 Panzem NCD 67 Initiates Phase II 67 Solid Tumors 67 CA9 SCAN 67 trastuzumab Herceptin R 67 HuMax CD# 67 Bosutinib 67 rilonacept 67 Novel Oral 67 Inhalation Solution 67 Seliciclib 67 CCR5 antagonist 67 OHR/AVR# 67 Cloretazine R VNP#M 67 Prosaptide 67 XL# XL# 67 Phase 2a Clinical Trial 67 Cethromycin 67 OvaRex ® MAb 67 Tarceva TM 67 Perforomist ™ Inhalation Solution 67 PSMA ADC 67 lexidronam injection 67 recurrent glioblastoma multiforme 67 clevidipine 67 Arcalyst 67 investigational monoclonal antibody 67 Blinatumomab 67 Anturol TM 67 briakinumab 67 mGluR2 positive 67 ritonavir boosted 67 Drug Candidate 67 refractory gout 67 Vidaza azacitidine 67 Glatiramer Acetate 67 Romiplostim 67 Ofatumumab 67 Tocilizumab 67 trastuzumab Herceptin ® 67 PI3K/Akt pathway inhibitor 67 Pivotal Phase 67 RSR# 67 Investigational Drug 67 SAR# [004] 67 BNC# 67 Denufosol 67 thetreatment 67 sitaxsentan 67 Varespladib 67 subcutaneous formulation 67 PEG SN# 67 PEG Interferon lambda 67 Cethrin R 66 icatibant 66 Cloretazine R 66 MAP# 66 DU #b 66 SinuNase TM 66 pomalidomide 66 refractory chronic lymphocytic 66 LY# [003] 66 serotonin norepinephrine reuptake inhibitor 66 Myocet 66 Elotuzumab 66 Phase 1b clinical 66 Simulect 66 Unit Dose Budesonide 66 OvaRex R 66 Oral NKTR 66 KNS # 66 HSP# inhibitor 66 Nexavar sorafenib 66 Refractory Angina 66 boosted protease inhibitor 66 Velcade bortezomib 66 velafermin 66 liposome injection 66 IgG1 monoclonal antibody 66 torezolid phosphate 66 mGluR5 NAM 66 Files IND 66 Phase IIB 66 TRX1 66 eltrombopag 66 castrate resistant prostate cancer 66 Initiates Clinical Trial 66 HQK 66 REMINYL ® 66 NGX# 66 Boceprevir 66 Decitabine 66 panitumumab Vectibix 66 rhIGF-I/rhIGFBP-3 66 novel VDA molecule 66 Triolex 66 EndoTAG TM -1 66 Amplimexon 66 Doxil ® 66 VA# [002] 66 IMA# 66 ADVANCE PD 66 CANCIDAS 66 GLP1 agonist 66 Pegloticase 66 lintuzumab SGN 66 Interferon beta 1a 66 Vertex hepatitis C 66 Phase 2a clinical trials 66 DEB# 66 maximally tolerated dose 66 painful diabetic neuropathy 66 OvaRex 66 Revlimid lenalidomide 66 oxypurinol 66 Candesartan 66 Belimumab 66 TELCYTA 66 phase Ib 66 OMNARIS HFA 66 Apoptone 66 Peginterferon 66 CIMZIA TM 66 pharmacodynamic properties 66 Phase 2a trial 66 PXD# 66 xanthine oxidase inhibitor 66 phase IIIb 66 orally dosed 66 phase IIb 66 EOquin 66 MGCD# [001] 66 etanercept Enbrel 66 ALGRX 66 nucleoside analog 66 Phenoptin 66 Rigel R# 66 Dose Ranging Study 66 efficacy tolerability 66 CEQ# 66 Phase IIa trial 66 alkylating agent 66 randomized Phase IIb 66 Arimoclomol 66 Anavex #-# 66 HCV NS5B polymerase 66 Noxafil 66 LUMINATE 66 Alocrest 66 GRN# 66 orBec 66 Diabetic Neuropathy 66 hormone LHRH antagonist 66 REOLYSIN ® 66 Preclinical Data 66 celgosivir 66 HDAC Inhibitor 66 MEND CABG II 66 relapsed MM 66 visilizumab 66 GSK# [001] 66 Tekamlo 66 Phase 2a 66 atacicept 66 huN# DM1 66 CB2 selective receptor agonist 66 bardoxolone methyl 66 Proellex TM 66 HGS ETR1 66 Elvitegravir 66 Wellstat 66 diarrhea predominant irritable 66 Maribavir 66 Randomized Double blind 66 #I TM# 66 MEK Inhibitor 66 miconazole Lauriad ® 66 Phase Ib 66 Myelodysplastic Syndrome MDS 66 tafamidis 66 Tezampanel 66 Ceflatonin 66 CCR5 mAb 66 OMS#HP 66 Aptivus ® 66 AZILECT R 66 Pegylated Interferon 66 pioglitazone hydrochloride 66 myelodysplastic myeloproliferative diseases 66 R sorafenib tablets 66 Pharmacokinetics PK 66 cetuximab Erbitux R 66 tocilizumab 66 Spiegelmer ® 66 antibody MAb 66 LEP ETU 66 Prospective Randomized 66 histamine dihydrochloride 66 Anti Tumor 66 Bioral ® 66 PREZISTA r 66 QLT# 66 Zenvia TM 66 Prednisporin TM 66 Xanafide 66 Aurora Kinase 66 anti amnesic 66 HCV SPRINT 66 Oracea TM 66 Phase 2b study 66 multi kinase inhibitor 66 Liprotamase 66 CRx 66 Capesaris 66 Tasimelteon 66 HuMax EGFr 66 EXPAREL ™ 66 regorafenib 66 Sprycel dasatinib 66 Dacogen injection 66 EP #R 66 candesartan cilexetil 66 Naive Patients 66 Anti VEGF 66 phase IIb study 66 non peptidic protease 66 rALLy clinical trial 66 Bayer Onyx 66 Sym# 66 Voreloxin 66 Exelixis compounds 66 desvenlafaxine 66 EXPAREL TM 66 SPRYCEL ® 66 JAK Inhibitor 66 Relapsed Multiple Myeloma 66 TRO# 66 FOLFOX6 chemotherapy regimen 66 IMiDs R 66 MYCAMINE 66 CCX# B 66 overactive bladder AA# 66 Serdaxin ® 66 Initiates Clinical 66 octreotide acetate 66 PSN# [001] 66 abatacept Orencia 66 angiogenesis inhibitor 66 UPLYSO 66 Alemtuzumab 66 Darinaparsin 66 VitiGam 66 GLPG# 66 Vandetanib 66 5 HT6 receptor 66 Medidur TM FA 66 BRIM2 66 AEG# 66 aflibercept 66 SCH # 66 bortezomib Velcade 66 Achieves Primary Endpoint 66 trastuzumab DM1 T DM1 66 Levetiracetam 66 nucleoside reverse transcriptase inhibitor 66 Investigational Oral 66 Eltrombopag 66 Microplasmin 66 severe hypercholesterolemia 66 APTIVUS r 66 DAVANAT 66 Nasulin ™ 66 Ecallantide 66 Ropinirole 66 Phase Ib clinical trials 66 INSPIRE Trial Phase III 66 ALN PCS 66 Triapine R 66 antiplatelet agent 66 Zarnestra 65 placebo controlled clinical 65 Deforolimus 65 Antitumor Activity 65 methylnaltrexone bromide 65 dirucotide MBP# 65 PEGylated interferon beta 1a 65 Rylomine 65 TO AVOID PREGNANCY WHILE 65 HGS# 65 Naproxcinod 65 constipation OIC 65 Abiraterone acetate 65 olaparib 65 Arranon 65 Ataluren 65 Initiates Phase 2b 65 Cetrorelix 65 proteasome inhibitor 65 viral kinetics 65 Liposomal 65 L BLP# 65 Monotherapy 65 Immunotherapeutic 65 STRIDE PD 65 Pivotal Study 65 Cardio Vascu Grow 65 Begins Dosing 65 Phase IIa 65 PANVAC VF 65 varespladib 65 Clevudine 65 SinuNase 65 Ramelteon 65 Acute Ischemic Stroke 65 Sanctura XR 65 Cutaneous T 65 ZYBRESTAT 65 Renal Cell Carcinoma 65 BEMA Buprenorphine 65 Zingo TM 65 Ceflatonin R 65 CINTREDEKIN BESUDOTOX 65 APEX PD 65 iniparib 65 Intravesical 65 IMC #B 65 ularitide 65 PROVENGE sipuleucel T 65 methylnaltrexone 65 Plenaxis TM 65 Rasagiline 65 endothelin receptor antagonists 65 polymerase inhibitor 65 Glufosfamide 65 Telavancin 65 Proxinium TM 65 PEGylated anti 65 Allovectin 7 65 standard chemotherapy regimen 65 ISENTRESS 65 Dacogen decitabine 65 Teriparatide 65 acetonide FA 65 Trofex 65 SNT MC# 65 bortezomib Velcade R 65 vemurafenib 65 TASKi2 65 Clonicel 65 Loxapine 65 demonstrated antitumor activity 65 Pulmonary Arterial Hypertension 65 immunomodulatory agents 65 Linagliptin 65 Pafuramidine 65 volociximab 65 Adentri 65 Investigational Compound 65 AZILECT ® 65 refractory APL 65 omacetaxine mepesuccinate 65 Lu AA# 65 CRLX# 65 TNF Tumor Necrosis Factor 65 paliperidone ER 65 investigational drug 65 Presents Preclinical 65 PEG PAL 65 phase 2a 65 cetuximab Erbitux 65 paclitaxel Taxol R 65 Frova ® 65 HCV protease inhibitors 65 gemcitabine Gemzar 65 Antiangiogenic 65 erlotinib Tarceva 65 BENICAR HCT 65 Demonstrates Positive 65 Navelbine ® 65 recurrent herpes labialis 65 Zolinza 65 desvenlafaxine succinate 65 ELADUR 65 Kamada AAT 65 Combination REOLYSIN R 65 CDP# 65 ropinirole Requip 65 beta 1a 65 advanced metastatic renal 65 orally bioavailable 65 Campath alemtuzumab 65 AKT inhibitor 65 transcriptase inhibitor NNRTI 65 tipranavir 65 VAPRISOL 65 VELCADE melphalan 65 mecamylamine 65 PF # [002] 65 Oxytrex TM 65 Tekturna HCT 65 HZT 65 investigational compound 65 FM VP4 65 5 HT3 antagonist 65 docetaxel Taxotere 65 Ketotransdel 65 investigational protease inhibitor 65 AVE# 65 atypical antipsychotic 65 HuLuc# 65 Study Evaluating 65 atrasentan 65 Phase #b/#a trial 65 Rebif ® 65 palifosfamide 65 BoNTA 65 Plecanatide 65 biologic therapy 65 Egrifta 65 Aripiprazole 65 HP Acthar Gel repository 65 Enzastaurin 65 MoxDuo IR 65 Bevacizumab 65 Danazol 65 LT NS# 65 evaluating satraplatin 65 Aclidinium 65 SUTENT ® 65 Abilify aripiprazole 65 mGlu2 3 65 Alequel 65 Plicera 65 Preclinical studies suggest 65 glycoprotein IIb IIIa inhibitor 65 novel emulsion formulation 65 Demonstrates Efficacy 65 5 FU leucovorin 65 CTAP# Capsules 65 multicenter Phase III 65 entinostat 65 trastuzumab emtansine T DM1 65 obatoclax 65 Phase Ib II 65 Paliperidone Palmitate 65 Mitoxantrone 65 Dabigatran etexilate 65 dexpramipexole 65 PEGINTRON TM 65 p# inhibitor 65 tasimelteon 65 amrubicin 65 histone deacetylase inhibitor 65 eniluracil 65 opioid induced bowel dysfunction 65 Phase IIb clinical trials 65 Gliadel Wafer 65 Paxil paroxetine 65 ISTODAX ® 65 Everolimus 65 subcutaneously administered 65 deforolimus 65 Nitazoxanide 65 Interferon Beta 65 SNT-MC#/idebenone 65 vinca alkaloid 65 Synavive 65 Ustekinumab 65 Omnitarg 65 lapatinib Tykerb 65 topical gel formulation 65 Genasense ® 65 FUSILEV enhances 65 Erlotinib 65 Squalamine 65 dopamine partial agonist 65 Auxilium transmucosal film 65 sargramostim 65 PLK1 SNALP 65 davunetide intranasal AL 65 Oral Spray 65 Orphan Status 65 Kinase Inhibitor 65 Sudhir Agrawal D.Phil 65 Previously Treated 65 CXB# 65 Zeldox 65 Well Tolerated 65 cilengitide 65 antifibrotic 65 aurora kinase 65 Abatacept 65 EGS# 65 Prolongs Survival 65 lenalidomide Revlimid R 65 CCR9 antagonist 65 Brentuximab Vedotin SGN 65 Dual Opioid 65 BCX# 65 OMAPRO ™ 65 Atrasentan 65 renin inhibitor 65 Aplidin 65 Atiprimod 65 BRAF inhibitor 65 guanfacine extended release 65 tipifarnib 65 AMEVIVE 65 cetuximab Erbitux ® 65 mitoxantrone plus 65 RSD# oral 65 Novel Antibiotic 65 ALVESCO R 65 AeroLEF TM 65 Solorel TM 65 2 methoxyestradiol 65 Herceptin trastuzumab 65 cromolyn sodium 65 intravesical infusion therapy 65 Prostate AdenoCarcinoma Treatment 65 Aztreonam lysine 65 albiglutide 65 R#/MEM 65 oral methylnaltrexone 65 TG# [003] 65 CYT# QbG# 65 Zelrix 65 intravenously administered 65 Celebrex celecoxib 65 Gemzar gemcitabine 65 estramustine 65 trodusquemine 65 Hormone Refractory Prostate Cancer 65 chemotherapy FOLFOX 65 cell lymphoma CTCL 65 Panzem 65 Cethrin 65 Roche Actemra 65 SILENOR 65 Oral Fingolimod 65 Peginterferon alfa 2b 65 Long Term Efficacy 65 ARIXTRA R 64 Cetuximab Erbitux 64 BZL# 64 alemtuzumab Campath 64 Octreolin 64 Troxatyl 64 Oral Calcitonin 64 oral Azacitidine 64 multitargeted 64 systemic immunosuppressive drugs 64 recurrent metastatic ovarian cancer 64 Receives Orphan Drug Designation 64 evaluating Xcytrin 64 assessing T DM1 64 Lenalidomide 64 Dose Escalation 64 Pivotal Trial 64 ocular formulation 64 imatinib Gleevec ® 64 Granted Orphan Drug 64 ONCONASE R 64 LCP AtorFen 64 ICA # 64 Soliris TM eculizumab 64 LHRH antagonist 64 cathepsin K inhibitor 64 Bosentan 64 nalbuphine ER 64 Olaparib 64 mycophenolate mofetil 64 BioNumerik 64 Menerba 64 markets Gelclair R 64 Protease Inhibitor 64 Phase III multicenter 64 metastatic castration resistant 64 Tasigna nilotinib 64 EndoTAGTM 1 64 lorvotuzumab mertansine 64 Presents Positive 64 multicenter Phase II 64 Sphingomab 64 Tesamorelin 64 NV1FGF 64 dose escalation clinical 64 CIMZIA ™ 64 Targretin capsules 64 Telik logo TELINTRA 64 registrational Phase 64 Locteron ® 64 treatment naive genotype 64 CoFactor 64 Pathway Inhibitor 64 ALN TTR# 64 MEND CABG 64 dyskinesia PD LID 64 Vidaza ® 64 Keryx Biopharma 64 abacavir Ziagen 64 Albuferon TM 64 Files Investigational 64 ATL# [002] 64 Trimesta 64 topical antifungal 64 Gefitinib 64 Mirapexin 64 HER2 positive metastatic breast 64 HGS ETR1 mapatumumab 64 MT# MEDI 64 agomelatine 64 rHuPH# recombinant human 64 metastatic malignant 64 Allovectin 7 ® 64 CA4P 64 Pralatrexate 64 combines bupropion 64 Fabry Disease 64 malignant ascites 64 lucinactant 64 CYCLOSET 64 citalopram Celexa 64 plus prednisone 64 AVASTIN 64 ZYBRESTAT fosbretabulin 64 NeuroSTAT ® 64 ARIKACE ™ 64 AVONEX ® 64 Vidofludimus 64 pan histone deacetylase 64 placebo controlled Phase III 64 hyperphenylalaninemia HPA due 64 Cariprazine 64 Glycopyrrolate 64 relapsed ovarian cancer 64 Icatibant 64 monoclonal antibody conjugated 64 SARMs 64 Phase IIb trials 64 decitabine 64 HERCEPTIN 64 preclinically 64 TAFA# 64 Avanafil 64 ORADUR ® 64 severe gastroparesis 64 POSIDUR TM 64 gemtuzumab ozogamicin 64 DEXILANT 64 Reverset 64 Alinia 64 ISTODAX 64 CG# [003] 64 BEMA TM Fentanyl 64 ATL/TV# 64 Huntexil 64 Apixaban 64 Cimzia TM 64 PROMACTA 64 vandetanib 64 apoptosis inducer 64 RELOVAIR ™ 64 orally administered inhibitor 64 Refractory Hodgkin Lymphoma 64 EVIZON ™ 64 TREANDA 64 Novolimus 64 HCl Tablets 64 HuMax CD4 64 LEVADEX 64 Quinamed 64 infliximab Remicade 64 amifostine 64 ALN HPN 64 REG2 64 Tiotropium 64 tenofovir emtricitabine 64 generation Hsp# inhibitor 64 Completes Enrollment 64 topiramate Topamax 64 Natalizumab 64 oral proteasome inhibitor 64 Ziprasidone 64 rALLy 64 vascular disrupting agent 64 Pivotal Clinical Trial 64 Lisofylline LSF 64 levocetirizine

Back to home page